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ABSTRACT. PURPOSE: Melatonin, the principle 
hormone of pineal gland plays an important role in 
several biological processes. The effects of 
melatonin on hepatic marker enzymes [aspartate and 
alanine transaminases (AST and ALT)], lipid peroxides 
[thiobarbituric acid reactive substances (TBARS)] and 
antioxidants [reduced glutathione (GSH), glutathione 
peroxidase (GPx) and glutathione-S-transferase (GST)] 
during N-nitrosodiethylamine (NDEA) – induced 
hepatocarcinogenesis in rats were studied. 
METHODS: Male albino Wistar rats of body weight 
150-170 g were divided into four groups of six animals 
each. Group I animals served as control, Group II 
animals received single intraperitoneal injection of 
NDEA at a dose of 200 mg/kg body weight followed 
by weekly subcutaneous injections of CCl4 at a dose of 3 
mL/kg body weight. Group III animals were treated as in 
Group II and melatonin (5 mg/kg body weight) was 
administered intraperitoneally. Group IV animals received 
melatonin alone at the same dose as Group III animals. 
RESULTS: A significant increase in the activities of 
serum AST and ALT was observed in NDEA treated 
rats when compared with control animals. Melatonin 
administered rats showed a significant decrease in the 
activities of these enzymes when compared with NDEA 
treated animals. In the liver of NDEA-treated animals, 
decreased lipid peroxidation associated with enhanced 
antioxidant levels was observed. Administration of 
melatonin positively modulated these changes. 
CONCLUSION: Our results indicate that melatonin 
exerts chemopreventive effect by restoring the activities 
of hepatic marker enzymes and reversing the oxidant-
antioxidant imbalance during NDEA-induced 
hepatocarcinogenesis.  
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INTRODUCTION 
Hepatocellular carcinoma is the fifth most common 
cancer in the world (1, 2). The major risk factors of 
this disease include hepatitis B and C viral 
infections, exposure to nitrosocompounds and 
aflatoxin B1 and alcoholic liver disease (3, 4). A 
number of endogenous and exogenous cancer risk 
factors generate oxygen free radicals in vivo (5, 6) and 
initiate carcinogenic process (7). N-
Nitrosodiethylamine (NDEA) is one of the most 
important environmental hepatocarcinogens that has 
been reported to generate free radicals to exert its 
carcinogenic effects (8) and it has been widely used 
in the field of experimental hepatocarcinogenesis 
(9,10). 
Several antioxidants with different 
efficacies protect against oxidative abuse caused by 
wide range of carcinogens including NDEA (11). 
Melatonin, N-acetyl-5-methoxytryptamine is a 
pineal gland hormone. It is a direct free radical 
scavenger, an indirect antioxidant and an 
immunomodulatory agent (12). It holds the unique 
position of being the only known chronobiotic 
regulator of neoplastic cell growth (13, 14). Both in 
vitro and on different animal models of tumorgenesis, 
melatonin has been found to inhibit neoplastic growth 
and to delay tumor progression (15, 16). The present 
study was designed to analyse the effect of melatonin 
on hepatic marker enzymes (aspartate and alanine 
transaminases), lipid peroxides (thiobarbituric acid 
reactive substances); glutathione and its dependent 
enzymes (glutathione peroxidase and glutathione-S-
transferase) during NDEA- induced 
hepatocarcinogenesis in rats.  
MATERIALS AND METHODS 
Animals 
Adult male Wistar rats (150-170 g) obtained from 
Central Animal House, Rajah Muthiah Medical 
College, Annamalai University, Annamalainagar 
were used in the present study. Commercial pellet 
diet (Kamdhenu agencies, Bangalore, India) and 
water were made available to the animals ad libitum. 
Animals were maintained in a controlled 
environment (temperature 30 ± 3 °C) with 12 h 
light/dark cycles in an experimental room simulating 
natural conditions. In Annamalainagar (11°24′N, 
79°42′E), the light dark (LD) cycle is almost 12:12 h 
throughout the year (17). The animals were maintained 
in accordance with the guidelines of National Institute of 
Nutrition, Indian Council of Medical Research, J Pharm Pharmaceut Sci (www.cspscanada.org) 8(2):316-321, 2005 
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Hyderabad, India and approved by the ethical 
committee, Annamalai University. 
Chemicals  
NDEA was purchased from Sigma Chemical Co., 
USA. Melatonin was purchased from Sisco Research 
Laboratories, Mumbai. All other chemicals used in 
the study were of analytical grade. 
Experimental induction of hepatocarcinogenesis 
One gram of NDEA was dissolved in 1mL of saline 
and administered to each rat at a dose of 200 mg/kg 
body weight once intraperitoneally (18), followed by 
subcutaneous injections of carbon tetrachloride 
(CCl4)   [3 mL/kg body weight/week] for 6 weeks  
(10). 
Experimental design  
Animals were divided into four groups of six animals 
each. Group I rats served as controls, Group II rats 
received single intraperitoneal injection of NDEA (200 
mg/kg body weight) followed by weekly subcutaneous 
injections of CCl4 (10). Animals in Group III were 
treated as in Group II, in addition melatonin [5 mg/kg 
body weight] (19) was administered intraperitoneally 
throughout the experimental period of 20 weeks. Group 
IV animals received melatonin alone at the same dose 
as group III animals. 
At the end of experimental period of 20 
weeks, the animals were sacrificed by cervical 
dislocation; blood samples and liver tissue were used 
for analysis. 
Preparation of tissue homogenate  
10% tissue homogenate was prepared using an 
appropriate buffer for the estimation of lipid 
peroxides and antioxidants. 
BIOCHEMICAL INVESTIGATIONS  
Serum aspartate and alanine transaminases (AST 
and ALT) 
The activities of these enzymes were estimated by the 
method of Reitman and Frankel (20). 0.2 mL of serum 
was added to 1 mL of phosphate buffer containing 
substrate, mixed and incubated for 60 minutes for AST 
and 30 minutes for ALT at 37°C. Then 1 mL of 
dinitrophenylhydrazine was added and incubated for 
20 minutes at room temperature and 10 mL of 0.4% 
sodium hydroxide was added, mixed well and after 
five minutes, read at 550 nm. Blank and a series of 
standards were processed similarly. 
Thiobarbituric acid reactive substances (TBARS) 
TBARS were assayed by the method of Niehaus and 
Samuelsson (21). To 1 mL of tissue homogenate, 2 
mL of TCA-TBA-HCl reagent was added, mixed 
thoroughly and kept in boiling water bath for 15 
minutes. The precipitate was removed by 
centrifugation. A series of standards was processed 
similarly and the absorbance was read at 535 nm. 
Reduced glutathione (GSH) 
GSH was estimated by the method of Ellman (22). 
0.5 mL of tissue homogenate was precipitated with 2 
mL of 5% TCA. After centrifugation, 1 mL of 
supernatant was taken and added 0.5 mL of Ellman’s 
reagent (19.8 mg of 5,5’ dithio(bis)nitrobenzoic acid 
in 100 mL of 1% sodium citrate) and 3 mL of 
phosphate buffer. Standards were treated in a similar 
way and the colour developed was read at 412 nm. 
Glutathione peroxidase (GPx) 
GPx activity was measured by the method of 
Rotruck et al. (23). To 0.2 mL of buffer, 0.2 mL of 
EDTA, 0.1 mL of sodium azide and 0.5 mL of tissue 
homogenate were added. To that mixture, 0.2 mL of 
glutathione solution and 0.1 mL of hydrogen 
peroxide were added. The contents were mixed well 
and incubated at 37°C for 10 minutes along with the 
control tubes containing all the reagents but no 
enzyme. After 10 minutes, the reaction was arrested 
by the addition of 0.4 mL of 10% TCA. 0.2 mL of 
tissue homogenate was added to the control tubes. 
The tubes were centrifuged and supernatant was 
assayed for glutathione content by adding Ellman’s 
reagent. 
Glutathione-S-transferase (GST) 
GST activity was measured by the method of Habig et 
al. (24). The reaction mixture containing 1 mL of buffer, 
0.1 mL of 1-chloro-2, 4-dinitrobenzene (CDNB), 0.1 mL 
of homogenate and 1.7 mL of distilled water was 
incubated at 37°C for 5 minutes. The reaction was then 
started by the addition of 1 mL of glutathione. The 
increase in absorbance was followed for 3 minutes at 
340 nm. The reaction mixture without the enzyme was 
used as blank. 
Statistical analysis 
Statistical analysis was carried out by analysis of 
variance (ANOVA) and the groups were compared 
using Duncan’s Multiple Range Test (DMRT). J Pharm Pharmaceut Sci (www.cspscanada.org) 8(2):316-321, 2005 
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RESULTS 
The activities of serum aspartate and alanine 
transaminases were found to be significantly higher 
in NDEA plus CCl4 treated rats when compared with 
control animals and lower in the animals treated with 
NDEA plus CCl4 as well as melatonin when 
compared with NDEA plus CCl4 treated animals. 
The animals treated with melatonin alone showed no 
significant change in the activities of transaminases 
(Table 1).  
The levels of thiobarbituric acid reactive 
substances in the liver of NDEA plus CCl4 treated 
animals were significantly decreased when compared 
with control animals. NDEA plus CCl4 as well as 
melatonin treated animals showed significantly 
increased levels of TBARS when compared with 
NDEA and CCl4 treated animals.  
 
Table 1. Changes in activities of serum aspartate and 
alanine transaminases (AST and ALT) 
 Control NDEA  NDEA  + 
Melatonin
Melatonin 
AST 
(IU/L)
92.15  ± 
5.40
a 
240.32 
± 
22.36
b 
130.33  ± 
8.50
c 
86.16  ± 
4.75
a 
ALT 
(IU/L)
38.66  ± 
2.50
a 
125.39 
± 
6.44
b 
54.12  ± 
2.60
c 
36.19  ± 
1.41
a 
ANOVA followed by Duncan’s multiple range test. 
Values not sharing a common superscript (a, b, c) differ 
significantly at p ≤ 0.05 
 
The animals treated with melatonin alone did 
not show any significant change in the levels of 
TBARS (Table 2).  
 
 
Table 2. Changes in the levels of TBARS and GSH and activities of GPx and GST in liver of experimental 
animals  
 Control  NDEA  +  CCl4  NDEA + CCl4 + 
Melatonin 
Melatonin  
TBARS (mmoles x 10
 -
3/mg protein) 
0.903 ± 0.072
a  0.148 ± 0.031
b  0.517 ± 0.049
c  0.911 ± 0.016
a 
GSH                      
(mg/mg protein) 
0.128± 0.07
 a 0.150  ± 0.09
b  0.134 ± 0.09
c  0.126 ± 0.08
a 
GPx                          
(U
A/mg protein) 
11.76 ± 0.71
 a 21.50  ± 1.78
b  15.26 ± 0.93
c  12.80 ± 0.71
a 
GST                       
(U
B/mg protein) 
690.53 ± 26.83
 a 1070.61  ± 44.72
b  820.19 ± 35.77
c  671.31 ±26.87
a 
U
A : μmoles of GSH utilized/min 
U
B : μmoles of CDNB-GSH conjugate formed/min  
ANOVA followed by Duncan’s multiple range test 
Values not sharing a common superscript (a, b, c) differ significantly at p ≤ 0.05 
 
The levels of GSH and the activities of 
glutathione peroxidase and glutathione-S-transferase 
in liver of NDEA plus CCl4 treated animals were 
significantly higher when compared with control 
animals. Administration of melatonin restored the 
levels of GSH and the activities of GPx and GST to 
near normal levels. The animals treated with 
melatonin alone showed no significant change in the 
levels of GSH and in the activities of GSH related 
enzymes (Table 2). 
DISCUSSION  
NDEA undergoes metabolic activation by 
cytochrome P450 enzymes to reactive electrophiles 
that are cytotoxic, mutagenic and carcinogenic (25). 
Serum transaminases are sensitive indicators of hepatic 
injury (26). Several reports have shown an increase in 
the activities of AST and ALT during NDEA-induced 
hepatocarcinognesis (27, 28). Elevated activities of 
serum AST and ALT observed in NDEA and CCl4 
treated rats may be due to NDEA induced hepatic 
damage and subsequent leakage of these enzymes into 
circulation. It has been reported that NDEA is 
transported through blood and it causes hepatic injury 
(8). Administration of melatonin restored the activities 
of these enzymes to near normal values, which may 
be attributed to the hepatoprotective role of 
melatonin.  
Although, several studies have demonstrated 
increased lipid peroxidation in liver during NDEA- 
induced hepatocarcinogenesis (27,29,30); in primary 
colon tumor (31) and in breast cancer tissue (32), we J Pharm Pharmaceut Sci (www.cspscanada.org) 8(2):316-321, 2005 
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observed decreased lipid peroxidation in the liver of 
NDEA plus CCl4 treated rats, as evidenced by 
thiobarbituric acid reactive substances. Oxidant-
antioxidant balance plays a significant role in the 
pathogenesis of cancer (32). Tumor cells generally 
display low levels of lipid peroxidation (33) which in 
turn can stimulate cell division and promote tumor 
growth (34, 35). It has been reported that mild 
oxidative stress stimulates while excessive oxidative 
stress inhibits cell growth (36, 37). Slater et al. 
proposed that rapidly dividing cells tend to set an 
oxidant-antioxidant status favourable to their growth 
(38). The decrease in lipid peroxidation observed in 
NDEA plus CCl4 treated animals may be due to 
stimulation of cell division and tumor promotion. Lipid 
peroxidation has been found decreased in NDEA-
induced hepatoma (39). In the present study, melatonin 
administration modulated the lipid peroxide levels to 
near normal levels that may be attributable to its 
inhibitory action on tumor cell proliferation. It has 
been well known that melatonin controls tumor cell 
proliferation (40, 41). 
A significant increase in GSH content and 
activities of GSH related enzymes, glutathione 
peroxidase and glutathione-S-transferase was 
observed in NDEA plus CCl4 treated rats, which may 
be due to over expression of these antioxidants 
during enhanced cell proliferation. Huang et al. have 
reported that GSH is increased in human 
hepatocellular carcinoma and this increased GSH 
level facilitates the growth of liver cancer cells (42). 
A number of studies have demonstrated an enhanced 
expression of the various GST isoforms in cancer 
tissue in comparison to normal tissue (43, 44). Ferruzzi 
et al. have reported that GSH concentration is higher in 
tumor than in normal tissues (45). 
Administration of melatonin reverted the 
NDEA induced alterations in GSH and GSH related 
enzyme activities in liver. Sugie et al. reported that 
melatonin inhibited development of hepatocellular 
adenomas and carcinomas induced by 
diethylnitrosamine and phenobarbital in both 
initiation and promotion phases (46). In conclusion, 
melatonin would exert a chemopreventive effect by 
restoring the activities of hepatic marker enzymes 
and reversing the oxidant-antioxidant imbalance 
during hepatocarcinogenesis.  
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